Results 131 to 140 of about 27,314 (241)

Diagnosis of intrahepatic cholangiocarcinoma with CEUS

open access: yesJournal Of Ultrasonography
Intrahepatic cholangiocarcinoma (ICC) is a rare, heterogeneous, highly lethal tumor of the biliary tract. Due to the lack of effective treatments, an early identification of ICC is essential to achieve the best outcome in terms of therapy and prognosis aiming for a curative intent.
Giancarlo Gismondo Velardi   +17 more
openaire   +3 more sources

Human Reg I Gene Is Up–Regulated in Intrahepatic Cholangiocarcinoma and Its Precursor Lesions [PDF]

open access: bronze, 2001
Kenichi Harada   +11 more
openalex   +1 more source

Staging for intrahepatic cholangiocarcinoma [PDF]

open access: yesLiver International, 2010
Junichi Arita, Norihiro Kokudo
openaire   +2 more sources

Intrahepatic Cholangiocarcinoma with Lymphoepithelioma-Like Component [PDF]

open access: bronze, 2001
Tse‐Ching Chen   +2 more
openalex   +1 more source

The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinoma [PDF]

open access: bronze, 2001
Kenichi Taguchi   +7 more
openalex   +1 more source

A Case of Mucin-producing Cholangiocarcinoma with Cystic Dilatation of the Intrahepatic Bile Duct.

open access: hybrid, 1991
Michinori Murayama   +4 more
openalex   +2 more sources

Aberrant CpG Island Methylation of Multiple Genes in Intrahepatic Cholangiocarcinoma [PDF]

open access: green, 2002
Sun Lee   +4 more
openalex   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma

open access: yesNature Communications
Intratumoral immune status influences tumor therapeutic response, but it remains largely unclear how the status determines therapies for patients with intrahepatic cholangiocarcinoma.
Jia-Cheng Lu   +29 more
doaj   +1 more source

Home - About - Disclaimer - Privacy